Global Next Generation Cancer Diagnostic Devices Industry Research Report 2020, Forecast to 2025

September 2020 | 135 pages | ID: G79EBDE0BFD7EN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Next Generation Cancer Diagnostic Devices market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Next Generation Cancer Diagnostic Devices is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Next Generation Cancer Diagnostic Devices industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Next Generation Cancer Diagnostic Devices by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Next Generation Cancer Diagnostic Devices market are discussed.

The market is segmented by types:

• Next Generation Sequencing
• qPCR & Multiplexing
• Lab-on%li%a%li%chip (LOAC)
• Protein Microarrays
• DNA Microarrays
• Reverse Transcriptase-PCR (RT-PCR)

It can be also divided by applications:

• Biomarker Development
• CTC Analysis
• Proteomic Analysis
• Epigenetic Analysis
• Genetic Analysis

And this report covers the historical situation, present status and the future prospects of the global Next Generation Cancer Diagnostic Devices market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• Roche Holding Ltd.?Switzerland)
• Affymetrix Inc.(US)
• Agilent Technologies Inc(Germany)
• Abbott Laboratories(US)
• QIAGEN N.V.(Germany)
• Siemens Healthcare(Germany)
• Thermo Fisher Scientific Inc.(US)
• Becton Dickinson and Co.(US)
• Illumina Inc.(US)
• Johnson & Johnson(US)
• Allegro Diagnostics Corp.(Brazil)
• GE Healthcare(England)
• Cepheid Inc.(US)
• Life Technologies Corp.(US)
• Luminex Corp.(US)

Report Includes:

• xx data tables and xx additional tables
• An overview of global Next Generation Cancer Diagnostic Devices market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Next Generation Cancer Diagnostic Devices market
• Profiles of major players in the industry, including Roche Holding Ltd.?Switzerland), Affymetrix Inc.(US), Agilent Technologies Inc(Germany), Abbott Laboratories(US), QIAGEN N.V.(Germany).....

Research Objectives

• To study and analyze the global Next Generation Cancer Diagnostic Devices consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Next Generation Cancer Diagnostic Devices market by identifying its various subsegments.
• Focuses on the key global Next Generation Cancer Diagnostic Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Next Generation Cancer Diagnostic Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Next Generation Cancer Diagnostic Devices submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Next Generation Cancer Diagnostic Devices Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Next Generation Cancer Diagnostic Devices Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 NEXT GENERATION CANCER DIAGNOSTIC DEVICES INDUSTRY OVERVIEW

2.1 Global Next Generation Cancer Diagnostic Devices Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Next Generation Cancer Diagnostic Devices Global Import Market Analysis
  2.1.2 Next Generation Cancer Diagnostic Devices Global Export Market Analysis
  2.1.3 Next Generation Cancer Diagnostic Devices Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Next Generation Sequencing
  2.2.2 qPCR & Multiplexing
  2.2.3 Lab-on- a- chip (LOAC)
  2.2.4 Protein Microarrays
  2.2.5 DNA Microarrays
  2.2.6 Reverse Transcriptase-PCR (RT-PCR)
2.3 Market Analysis by Application
  2.3.1 Biomarker Development
  2.3.2 CTC Analysis
  2.3.3 Proteomic Analysis
  2.3.4 Epigenetic Analysis
  2.3.5 Genetic Analysis
2.4 Global Next Generation Cancer Diagnostic Devices Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Next Generation Cancer Diagnostic Devices Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Next Generation Cancer Diagnostic Devices Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Next Generation Cancer Diagnostic Devices Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Next Generation Cancer Diagnostic Devices Manufacturer Market Share
  2.4.5 Top 10 Next Generation Cancer Diagnostic Devices Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Next Generation Cancer Diagnostic Devices Market
  2.4.7 Key Manufacturers Next Generation Cancer Diagnostic Devices Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Next Generation Cancer Diagnostic Devices Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Next Generation Cancer Diagnostic Devices Industry Impact
  2.7.1 How the Covid-19 is Affecting the Next Generation Cancer Diagnostic Devices Industry
  2.7.2 Next Generation Cancer Diagnostic Devices Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Next Generation Cancer Diagnostic Devices Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Next Generation Cancer Diagnostic Devices Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL NEXT GENERATION CANCER DIAGNOSTIC DEVICES MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Region
4.2 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Region (2015-2019)
4.3 Global Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Next Generation Cancer Diagnostic Devices Market Size Detail
  4.4.1 North America Next Generation Cancer Diagnostic Devices Sales Growth Rate (2015-2020)
  4.4.2 North America Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Next Generation Cancer Diagnostic Devices Market Size Detail
  4.5.1 Europe Next Generation Cancer Diagnostic Devices Sales Growth Rate (2015-2020)
  4.5.2 Europe Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Next Generation Cancer Diagnostic Devices Market Size Detail
  4.6.1 Japan Next Generation Cancer Diagnostic Devices Sales Growth Rate (2015-2020)
  4.6.2 Japan Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Next Generation Cancer Diagnostic Devices Market Size Detail
  4.7.1 China Next Generation Cancer Diagnostic Devices Sales Growth Rate (2015-2020)
  4.7.2 China Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL NEXT GENERATION CANCER DIAGNOSTIC DEVICES MARKET SEGMENT BY TYPE

5.1 Global Next Generation Cancer Diagnostic Devices Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Next Generation Cancer Diagnostic Devices Sales and Market Share by Type (2015-2020)
  5.1.2 Global Next Generation Cancer Diagnostic Devices Revenue and Market Share by Type (2015-2020)
5.2 Next Generation Sequencing Sales Growth Rate and Price
  5.2.1 Global Next Generation Sequencing Sales Growth Rate (2015-2020)
  5.2.2 Global Next Generation Sequencing Price (2015-2020)
5.3 qPCR & Multiplexing Sales Growth Rate and Price
  5.3.1 Global qPCR & Multiplexing Sales Growth Rate (2015-2020)
  5.3.2 Global qPCR & Multiplexing Price (2015-2020)
5.4 Lab-on- a- chip (LOAC) Sales Growth Rate and Price
  5.4.1 Global Lab-on- a- chip (LOAC) Sales Growth Rate (2015-2020)
  5.4.2 Global Lab-on- a- chip (LOAC) Price (2015-2020)
5.5 Protein Microarrays Sales Growth Rate and Price
  5.5.1 Global Protein Microarrays Sales Growth Rate (2015-2020)
  5.5.2 Global Protein Microarrays Price (2015-2020)
5.6 DNA Microarrays Sales Growth Rate and Price
  5.6.1 Global DNA Microarrays Sales Growth Rate (2015-2020)
  5.6.2 Global DNA Microarrays Price (2015-2020)
5.7 Reverse Transcriptase-PCR (RT-PCR) Sales Growth Rate and Price
  5.7.1 Global Reverse Transcriptase-PCR (RT-PCR) Sales Growth Rate (2015-2020)
  5.7.2 Global Reverse Transcriptase-PCR (RT-PCR) Price (2015-2020)

6 GLOBAL NEXT GENERATION CANCER DIAGNOSTIC DEVICES MARKET SEGMENT BY APPLICATION

6.1 Global Next Generation Cancer Diagnostic DevicesSales Market Share by Application (2015-2020)
6.2 Biomarker Development Sales Growth Rate (2015-2020)
6.3 CTC Analysis Sales Growth Rate (2015-2020)
6.4 Proteomic Analysis Sales Growth Rate (2015-2020)
6.5 Epigenetic Analysis Sales Growth Rate (2015-2020)
6.6 Genetic Analysis Sales Growth Rate (2015-2020)

7 GLOBAL NEXT GENERATION CANCER DIAGNOSTIC DEVICES MARKET FORECAST

7.1 Global Next Generation Cancer Diagnostic Devices Sales, Revenue Forecast
  7.1.1 Global Next Generation Cancer Diagnostic Devices Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Next Generation Cancer Diagnostic Devices Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Next Generation Cancer Diagnostic Devices Price and Trend Forecast (2020-2025)
7.2 Global Next Generation Cancer Diagnostic Devices Sales Forecast by Region (2020-2025)
  7.2.1 North America Next Generation Cancer Diagnostic Devices Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Next Generation Cancer Diagnostic Devices Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Next Generation Cancer Diagnostic Devices Production, Revenue Forecast (2020-2025)
  7.2.4 China Next Generation Cancer Diagnostic Devices Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF NEXT GENERATION CANCER DIAGNOSTIC DEVICES INDUSTRY KEY MANUFACTURERS

8.1 Roche Holding Ltd.?Switzerland)
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 Roche Holding Ltd.?Switzerland) News
8.2 Affymetrix Inc.(US)
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Affymetrix Inc.(US) News
8.3 Agilent Technologies Inc(Germany)
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Agilent Technologies Inc(Germany) News
8.4 Abbott Laboratories(US)
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Abbott Laboratories(US) News
8.5 QIAGEN N.V.(Germany)
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 QIAGEN N.V.(Germany) News
8.6 Siemens Healthcare(Germany)
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 Siemens Healthcare(Germany) News
8.7 Thermo Fisher Scientific Inc.(US)
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 Thermo Fisher Scientific Inc.(US) News
8.8 Becton Dickinson and Co.(US)
  8.8.1 Company Details
  8.8.2 Product Information
  8.8.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.8.4 Main Business Overview
  8.8.5 Becton Dickinson and Co.(US) News
8.9 Illumina Inc.(US)
  8.9.1 Company Details
  8.9.2 Product Information
  8.9.3 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.9.4 Main Business Overview
  8.9.5 Illumina Inc.(US) News
8.10 Johnson & Johnson(US)
  8.10.1 Company Details
  8.10.2 Product Information
  8.10.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.10.4 Main Business Overview
  8.10.5 Johnson & Johnson(US) News
8.11 Allegro Diagnostics Corp.(Brazil)
  8.11.1 Company Details
  8.11.2 Product Information
  8.11.3 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.11.4 Main Business Overview
  8.11.5 Allegro Diagnostics Corp.(Brazil) News
8.12 GE Healthcare(England)
  8.12.1 Company Details
  8.12.2 Product Information
  8.12.3 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.12.4 Main Business Overview
  8.12.5 GE Healthcare(England) News
8.13 Cepheid Inc.(US)
  8.13.1 Company Details
  8.13.2 Product Information
  8.13.3 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.13.4 Main Business Overview
  8.13.5 Cepheid Inc.(US) News
8.14 Life Technologies Corp.(US)
  8.14.1 Company Details
  8.14.2 Product Information
  8.14.3 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.14.4 Main Business Overview
  8.14.5 Life Technologies Corp.(US) News
8.15 Luminex Corp.(US)
  8.15.1 Company Details
  8.15.2 Product Information
  8.15.3 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.15.4 Main Business Overview
  8.15.5 Luminex Corp.(US) News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Next Generation Cancer Diagnostic Devices Picture
Figure Research Programs/Design for This Report
Figure Global Next Generation Cancer Diagnostic Devices Market by Regions (2019)
Table Global Market Next Generation Cancer Diagnostic Devices Comparison by Regions (M USD) 2019-2025
Table Global Next Generation Cancer Diagnostic Devices Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Next Generation Cancer Diagnostic Devices by Type in 2019
Figure Next Generation Sequencing Picture
Figure qPCR & Multiplexing Picture
Figure Lab-on- a- chip (LOAC) Picture
Figure Protein Microarrays Picture
Figure DNA Microarrays Picture
Figure Reverse Transcriptase-PCR (RT-PCR) Picture
Table Global Next Generation Cancer Diagnostic Devices Sales by Application (2019-2025)
Figure Global Next Generation Cancer Diagnostic Devices Sales Market Share by Application in 2019
Figure Biomarker Development Picture
Figure CTC Analysis Picture
Figure Proteomic Analysis Picture
Figure Epigenetic Analysis Picture
Figure Genetic Analysis Picture
Table Global Next Generation Cancer Diagnostic Devices Sales by Manufacturer (2018-2020)
Figure Global Next Generation Cancer Diagnostic Devices Sales Market Share by Manufacturer in 2019
Table Global Next Generation Cancer Diagnostic Devices Revenue by Manufacturer (2018-2020)
Figure Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Manufacturer in 2019
Table Global Next Generation Cancer Diagnostic Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Next Generation Cancer Diagnostic Devices Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Next Generation Cancer Diagnostic Devices Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Next Generation Cancer Diagnostic Devices Market
Table Key Manufacturers Next Generation Cancer Diagnostic Devices Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Next Generation Cancer Diagnostic Devices
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Next Generation Cancer Diagnostic Devices Sales (K Units) by Region (2015-2020)
Table Global Next Generation Cancer Diagnostic Devices Sales Market Share by Region (2015-2019)
Figure Global Next Generation Cancer Diagnostic Devices Sales Market Share by Region (2015-2019)
Figure Global Next Generation Cancer Diagnostic Devices Sales Market Share by Region in 2018
Table Global Next Generation Cancer Diagnostic Devices Revenue (Million US$) by Region (2015-2020)
Table Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Region (2015-2020)
Figure Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Region (2015-2020)
Figure Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Region in 2019
Table Global Next Generation Cancer Diagnostic Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Next Generation Cancer Diagnostic Devices Sales (K Units) Growth Rate (2015-2020)
Table North America Next Generation Cancer Diagnostic Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Next Generation Cancer Diagnostic Devices Sales (K Units) Growth Rate (2015-2020)
Table Europe Next Generation Cancer Diagnostic Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Next Generation Cancer Diagnostic Devices Sales (K Units) Growth Rate (2015-2020)
Table Japan Next Generation Cancer Diagnostic Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Next Generation Cancer Diagnostic Devices Sales (K Units) Growth Rate (2015-2020)
Table China Next Generation Cancer Diagnostic Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Next Generation Cancer Diagnostic Devices Sales by Type (2015-2020)
Table Global Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2015-2020)
Figure Global Next Generation Cancer Diagnostic Devices Sales Market Share by Type in 2019
Table Global Next Generation Cancer Diagnostic Devices Revenue by Type (2015-2020)
Table Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Type (2015-2020)
Figure Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Type in 2019
Figure Global Next Generation Sequencing Sales Growth Rate (2015-2020)
Figure Global Next Generation Sequencing Price (2015-2020)
Figure Global qPCR & Multiplexing Sales Growth Rate (2015-2020)
Figure Global qPCR & Multiplexing Price (2015-2020)
Figure Global Lab-on- a- chip (LOAC) Sales Growth Rate (2015-2020)
Figure Global Lab-on- a- chip (LOAC) Price (2015-2020)
Figure Global Protein Microarrays Sales Growth Rate (2015-2020)
Figure Global Protein Microarrays Price (2015-2020)
Figure Global DNA Microarrays Sales Growth Rate (2015-2020)
Figure Global DNA Microarrays Price (2015-2020)
Figure Global Reverse Transcriptase-PCR (RT-PCR) Sales Growth Rate (2015-2020)
Figure Global Reverse Transcriptase-PCR (RT-PCR) Price (2015-2020)
Table Global Next Generation Cancer Diagnostic Devices Sales by Application (2015-2020)
Table Global Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2015-2020)
Figure Global Next Generation Cancer Diagnostic Devices Sales Market Share by Application in 2019
Figure Global Biomarker Development Sales Growth Rate (2015-2020)
Figure Global CTC Analysis Sales Growth Rate (2015-2020)
Figure Global Proteomic Analysis Sales Growth Rate (2015-2020)
Figure Global Epigenetic Analysis Sales Growth Rate (2015-2020)
Figure Global Genetic Analysis Sales Growth Rate (2015-2020)
Figure Global Next Generation Cancer Diagnostic Devices Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Next Generation Cancer Diagnostic Devices Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Next Generation Cancer Diagnostic Devices Price and Trend Forecast (2020-2025)
Table Global Next Generation Cancer Diagnostic Devices Sales (K Units) Forecast by Region (2020-2025)
Figure Global Next Generation Cancer Diagnostic Devices Production Market Share Forecast by Region (2020-2025)
Figure North America Next Generation Cancer Diagnostic Devices Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Next Generation Cancer Diagnostic Devices Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Next Generation Cancer Diagnostic Devices Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Next Generation Cancer Diagnostic Devices Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Next Generation Cancer Diagnostic Devices Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Next Generation Cancer Diagnostic Devices Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Next Generation Cancer Diagnostic Devices Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Next Generation Cancer Diagnostic Devices Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Roche Holding Ltd.?Switzerland) Company Profile
Figure Next Generation Cancer Diagnostic Devices Product Picture and Specifications of Roche Holding Ltd.?Switzerland)
Table Next Generation Cancer Diagnostic Devices Production, Price, Revenue and Gross Margin of 2018-2020
Figure Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Market Share (2018-2020)
Table Roche Holding Ltd.?Switzerland) Main Business
Table Roche Holding Ltd.?Switzerland) Recent Development
Table Affymetrix Inc.(US) Company Profile
Figure Next Generation Cancer Diagnostic Devices Product Picture and Specifications of Affymetrix Inc.(US)
Table Next Generation Cancer Diagnostic Devices Production, Price, Revenue and Gross Margin of 2018-2020
Figure Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Market Share (2018-2020)
Table Affymetrix Inc.(US) Main Business
Table Affymetrix Inc.(US) Recent Development
Table Agilent Technologies Inc(Germany) Company Profile
Figure Next Generation Cancer Diagnostic Devices Product Picture and Specifications of Agilent Technologies Inc(Germany)
Table Next Generation Cancer Diagnostic Devices Production, Price, Revenue and Gross Margin of 2018-2020
Figure Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Market Share (2018-2020)
Table Agilent Technologies Inc(Germany) Main Business
Table Agilent Technologies Inc(Germany) Recent Development
Table Abbott Laboratories(US) Company Profile
Figure Next Generation Cancer Diagnostic Devices Product Picture and Specifications of Abbott Laboratories(US)
Table Next Generation Cancer Diagnostic Devices Production, Price, Revenue and Gross Margin of 2018-2020
Figure Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Market Share (2018-2020)
Table Abbott Laboratories(US) Main Business
Table Abbott Laboratories(US) Recent Development
Table QIAGEN N.V.(Germany) Company Profile
Figure Next Generation Cancer Diagnostic Devices Product Picture and Specifications of QIAGEN N.V.(Germany)
Table Next Generation Cancer Diagnostic Devices Production, Price, Revenue and Gross Margin of 2018-2020
Figure QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Market Share (2018-2020)
Table QIAGEN N.V.(Germany) Main Business
Table QIAGEN N.V.(Germany) Recent Development
Table Siemens Healthcare(Germany) Company Profile
Figure Next Generation Cancer Diagnostic Devices Product Picture and Specifications of Siemens Healthcare(Germany)
Table Next Generation Cancer Diagnostic Devices Production, Price, Revenue and Gross Margin of 2018-2020
Figure Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Market Share (2018-2020)
Table Siemens Healthcare(Germany) Main Business
Table Siemens Healthcare(Germany) Recent Development
Table Thermo Fisher Scientific Inc.(US) Company Profile
Figure Next Generation Cancer Diagnostic Devices Product Picture and Specifications of Thermo Fisher Scientific Inc.(US)
Table Next Generation Cancer Diagnostic Devices Production, Price, Revenue and Gross Margin of 2018-2020
Figure Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Market Share (2018-2020)
Table Thermo Fisher Scientific Inc.(US) Main Business
Table Thermo Fisher Scientific Inc.(US) Recent Development
Table Becton Dickinson and Co.(US) Company Profile
Figure Next Generation Cancer Diagnostic Devices Product Picture and Specifications of Becton Dickinson and Co.(US)
Table Next Generation Cancer Diagnostic Devices Production, Price, Revenue and Gross Margin of 2018-2020
Figure Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Market Share (2018-2020)
Table Becton Dickinson and Co.(US) Main Business
Table Becton Dickinson and Co.(US) Recent Development
Table Illumina Inc.(US) Company Profile
Figure Next Generation Cancer Diagnostic Devices Product Picture and Specifications of Illumina Inc.(US)
Table Next Generation Cancer Diagnostic Devices Production, Price, Revenue and Gross Margin of 2018-2020
Figure Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Market Share (2018-2020)
Table Illumina Inc.(US) Main Business
Table Illumina Inc.(US) Recent Development
Table Johnson & Johnson(US) Company Profile
Figure Next Generation Cancer Diagnostic Devices Product Picture and Specifications of Johnson & Johnson(US)
Table Next Generation Cancer Diagnostic Devices Production, Price, Revenue and Gross Margin of 2018-2020
Figure Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Market Share (2018-2020)
Table Johnson & Johnson(US) Main Business
Table Johnson & Johnson(US) Recent Development
Table Allegro Diagnostics Corp.(Brazil) Company Profile
Figure Next Generation Cancer Diagnostic Devices Product Picture and Specifications of Allegro Diagnostics Corp.(Brazil)
Table Next Generation Cancer Diagnostic Devices Production, Price, Revenue and Gross Margin of 2018-2020
Figure Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Market Share (2018-2020)
Table Allegro Diagnostics Corp.(Brazil) Main Business
Table Allegro Diagnostics Corp.(Brazil) Recent Development
Table GE Healthcare(England) Company Profile
Figure Next Generation Cancer Diagnostic Devices Product Picture and Specifications of GE Healthcare(England)
Table Next Generation Cancer Diagnostic Devices Production, Price, Revenue and Gross Margin of 2018-2020
Figure GE Healthcare(England) Next Generation Cancer Diagnostic Devices Market Share (2018-2020)
Table GE Healthcare(England) Main Business
Table GE Healthcare(England) Recent Development
Table Cepheid Inc.(US) Company Profile
Figure Next Generation Cancer Diagnostic Devices Product Picture and Specifications of Cepheid Inc.(US)
Table Next Generation Cancer Diagnostic Devices Production, Price, Revenue and Gross Margin of 2018-2020
Figure Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Market Share (2018-2020)
Table Cepheid Inc.(US) Main Business
Table Cepheid Inc.(US) Recent Development
Table Life Technologies Corp.(US) Company Profile
Figure Next Generation Cancer Diagnostic Devices Product Picture and Specifications of Life Technologies Corp.(US)
Table Next Generation Cancer Diagnostic Devices Production, Price, Revenue and Gross Margin of 2018-2020
Figure Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Market Share (2018-2020)
Table Life Technologies Corp.(US) Main Business
Table Life Technologies Corp.(US) Recent Development
Table Luminex Corp.(US) Company Profile
Figure Next Generation Cancer Diagnostic Devices Product Picture and Specifications of Luminex Corp.(US)
Table Next Generation Cancer Diagnostic Devices Production, Price, Revenue and Gross Margin of 2018-2020
Figure Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Market Share (2018-2020)
Table Luminex Corp.(US) Main Business
Table Luminex Corp.(US) Recent Development
Table of Appendix